1. Home
  2. CPD Activities
  3. Activity Details

CPD Activity Details


Raising Awareness and Promoting Timely Diagnosis of ATTR Cardiac Amyloidosis in Kenya
Starting on:
Nov 12, 2025
Ending on:
Aug 11, 2026
Moderator(s):
Mr. John Dawod
Public Health Researcher and Clinical Operations Leader; Founder and Chairman of CRK Clinical Research Key (CRK-NGO) and CliniQuest Research Site, Nairobi. Principal Investigator for the national ATTR cardiac amyloidosis awareness and diagnosis program in collaboration with the Kenya Cardiac Society and Mayo Clinic. MSc in International Public Health (Liverpool John Moores University); experienced in digital health, clinical research, pharmacovigilance, and CPD-accredited e-learning development.
URL:
Go to activity

Max Credits:
60 Points

Provider:
CRK CLINICAL RESEARCH KEY (CRO) LIMITED
Claim Points

Raising Awareness and Promoting Timely Diagnosis of ATTR Cardiac Amyloidosis in Kenya

Starting on:
Nov 12, 2025
Ending on:
Aug 11, 2026
Venue:
The course is delivered entirely online and self-paced through CRKCourses.com. The course link: https://crkcourses.com/courses/attr-cardiac-amyloidosis_free_course/

Description

This free national online CPD course trains healthcare professionals to recognize, diagnose, and manage transthyretin cardiac amyloidosis (ATTR-CM). It consists of six structured modules delivered through explanation videos, illustrations, and interactive case studies hosted on CRKCourses.com. Each module includes quizzes and assessments designed to build stepwise competence — from understanding amyloidosis biology to applying diagnostic algorithms, interpreting imaging and genetic results, and planning treatment and follow-up. Participants complete a pre-test and final assessment to earn accredited CPD points and a digital certificate issued by CRK Clinical Research Key (CRK NGO). Course link: https://crkcourses.com/courses/attr-cardiac-amyloidosis_free_course/

Objectives

Explain the pathophysiology and classification of amyloidosis, including ATTR and AL types. Identify early clinical and imaging red flags suggestive of transthyretin cardiac amyloidosis (ATTR-CM). Apply diagnostic algorithms, including monoclonal protein screening and bone scintigraphy. Differentiate hereditary and wild-type ATTR using biopsy, genetic testing, and cardiac MRI. Describe staging systems and evidence-based treatment and monitoring strategies. Integrate knowledge through real-world case studies to improve early detection and patient outcomes in Kenya.

Presenters

  1. Prof. Anders Barasa
    Consultant Cardiologist and Heart Failure Specialist (MD, PhD); Section Head, Heart Failure Unit, Amager and Hvidovre Hospital, University of Copenhagen. Clinical Associate Professor, University of Copenhagen; Member of the Kenya Cardiac Society; former Research Lead and Consultant Cardiologist at Aga Khan University Hospital, Nairobi; internationally published expert in cardiac amyloidosis, heart failure, and clinical research.
    Kenya Cardiac Society

Login

Have an account?

Forgot Password?

Search For CPD Activity